Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy
Farzana Karim, Sandra C. Roerig, David SaphierVolume:
52
Year:
1996
Language:
english
Pages:
693
DOI:
10.1016/0006-2952(96)00346-2
File:
PDF, 1.06 MB
english, 1996